[go: up one dir, main page]

WO2009147178A3 - Nouvelle utilisation médicale de pyridin-2-ylméthylsulfinyl-1h-benzimidazoles substitués - Google Patents

Nouvelle utilisation médicale de pyridin-2-ylméthylsulfinyl-1h-benzimidazoles substitués Download PDF

Info

Publication number
WO2009147178A3
WO2009147178A3 PCT/EP2009/056824 EP2009056824W WO2009147178A3 WO 2009147178 A3 WO2009147178 A3 WO 2009147178A3 EP 2009056824 W EP2009056824 W EP 2009056824W WO 2009147178 A3 WO2009147178 A3 WO 2009147178A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
ylmethylsulphinyl
brain edema
substituted pyridin
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/056824
Other languages
English (en)
Other versions
WO2009147178A2 (fr
Inventor
Hartmut Heinze
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Nycomed GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed GmbH filed Critical Nycomed GmbH
Publication of WO2009147178A2 publication Critical patent/WO2009147178A2/fr
Publication of WO2009147178A3 publication Critical patent/WO2009147178A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention porte sur une nouvelle utilisation de pyridyl-2-méthylsulfinylbenzimidazoles substitués pour le traitement et/ou la prophylaxie d'un œdème cérébral.
PCT/EP2009/056824 2008-06-04 2009-06-03 Nouvelle utilisation médicale de pyridin-2-ylméthylsulfinyl-1h-benzimidazoles substitués Ceased WO2009147178A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08157528 2008-06-04
EP08157528.4 2008-06-04

Publications (2)

Publication Number Publication Date
WO2009147178A2 WO2009147178A2 (fr) 2009-12-10
WO2009147178A3 true WO2009147178A3 (fr) 2010-03-18

Family

ID=39870104

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/056824 Ceased WO2009147178A2 (fr) 2008-06-04 2009-06-03 Nouvelle utilisation médicale de pyridin-2-ylméthylsulfinyl-1h-benzimidazoles substitués

Country Status (1)

Country Link
WO (1) WO2009147178A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074811A2 (fr) * 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Composes de 1,3-thiazole substitues, production et utilisation desdits composes
WO2007064274A1 (fr) * 2005-11-30 2007-06-07 Astrazeneca Ab Forme de dosage pharmaceutique pour la voie orale comprenant comme ingrédients actifs un inhibiteur de la pompe à protons ainsi que de l'acide acétylsalicylique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074811A2 (fr) * 2000-03-30 2001-10-11 Takeda Chemical Industries, Ltd. Composes de 1,3-thiazole substitues, production et utilisation desdits composes
WO2007064274A1 (fr) * 2005-11-30 2007-06-07 Astrazeneca Ab Forme de dosage pharmaceutique pour la voie orale comprenant comme ingrédients actifs un inhibiteur de la pompe à protons ainsi que de l'acide acétylsalicylique

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JAVAHERI S ET AL: "Different effects of omeprazole and Sch 28080 on canine cerebrospinal fluid production", BRAIN RESEARCH 19970418 NL, vol. 754, no. 1-2, 18 April 1997 (1997-04-18), pages 321 - 324, XP007906112, ISSN: 0006-8993 *
JOCHEM V ET AL: "Fulminant hepatic failure related to omeprazole.", THE AMERICAN JOURNAL OF GASTROENTEROLOGY APR 1992, vol. 87, no. 4, April 1992 (1992-04-01), pages 523 - 525, XP007906130, ISSN: 0002-9270 *
LINDVALL-AXELSSON M ET AL: "Inhibition of cerebrospinal fluid formation by omeprazole", EXPERIMENTAL NEUROLOGY, ACADEMIC PRESS, NEW YORK, NY, US, vol. 115, no. 3, 1 March 1992 (1992-03-01), pages 394 - 399, XP022980519, ISSN: 0014-4886, [retrieved on 19920301] *
RABINSTEIN ALEJANDRO A: "Treatment of cerebral edema", NEUROLOGIST, WLLIAMS AND WILKINS, BALTIMORE, MD, US, vol. 12, no. 2, 1 May 2006 (2006-05-01), pages 59 - 73, XP009107834, ISSN: 1074-7931 *
RASLAN, BHARDWAJ: "Medical management of cerebral edema", NEUROSURG FOCUS, vol. 22, 2007, pages 1 - 12, XP007906107 *

Also Published As

Publication number Publication date
WO2009147178A2 (fr) 2009-12-10

Similar Documents

Publication Publication Date Title
WO2012045089A3 (fr) Méthodes de traitement de maladies allergiques
MX2010007490A (es) Preparacion de derivados de sulfamida.
IN2012DN00624A (fr)
MX2009013353A (es) Compuestos activadores de telomerasa y metodos para su uso.
WO2012064667A3 (fr) Traitement d'addiction et de troubles de contrôle des impulsions au moyen d'inhibiteurs de la pde7
AU2007208169A8 (en) Use of gallium to treat biofilm-associated infectons
WO2010036395A3 (fr) Traitement de l’exposition aux organophosphates au moyen de composés de tétrahydroindolone arylpipérazine
WO2011091366A3 (fr) Procédés de traitement ou de prévention de la parodontite et maladies associées à la parodontite
IL207220A0 (en) Methods for the treatment and prevention of age-related retinal dysfunction
WO2011163452A8 (fr) Traitement des troubles de la surface des yeux
WO2011071995A9 (fr) Composés et procédés de traitement de troubles oculaires
IL210997A0 (en) Compositions for the treatment of mrsa and uses thereof
WO2013098416A3 (fr) Composes anti-douleur
IN2014CN04014A (fr)
IL211313A0 (en) Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
IL210953A0 (en) Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof
IL207965A (en) Compounds to treat or prevent pain
EP2207555A4 (fr) Nouveaux composés pour le traitement ou l'atténuation des oedèmes, et leurs méthodes d'utilisation
WO2009136997A3 (fr) Inhibiteurs des cathepsines l, b et s humaines
MX2013002121A (es) Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
PT3330383T (pt) Grn163l para utiliização como inibidor de telomerase no tratamento de cancro
WO2009123486A8 (fr) Utilisation de composés pour le traitement de cytotoxicités induites par la protéine tau
WO2013176877A3 (fr) Traitement de la dépendance et des troubles du contrôle des impulsions à l'aide d'inhibiteurs de pde7
IL215235A (en) An antimicrobial compound, a drug containing the compound, the use of a compound for the preparation of a preparation for the prevention or treatment of a digestive ulcer
MX2011013324A (es) Uso de derivados de oxindol sustituidos para el tratamiento y profilaxis del dolor.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09757559

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09757559

Country of ref document: EP

Kind code of ref document: A2